Takeda Pharmaceutical
TAK
#512
Rank
ยฃ37.30 B
Marketcap
ยฃ11.81
Share price
1.36%
Change (1 day)
7.41%
Change (1 year)

EPS for Takeda Pharmaceutical (TAK)

EPS in 2025 (TTM): ยฃ0.42

According to Takeda Pharmaceutical's latest financial reports the company's current EPS (TTM) is ยฃ0.42. a decrease over its 2024 EPS that were of ยฃ0.23.

EPS history for Takeda Pharmaceutical from 2000 to 2025

Annual EPS

Year EPS Change
2025ยฃ0.17-25.03%
2024ยฃ0.23-60.3%
2023ยฃ0.5826.77%
2022ยฃ0.46-44.4%
2021ยฃ0.82722.5%
2020ยฃ0.09982-79.14%
2019ยฃ0.48-43.73%
2018ยฃ0.8570.24%
2017ยฃ0.5045.47%
2016ยฃ0.34-158.86%
2015-ยฃ0.58-217.99%
2014ยฃ0.49-34.43%
2013ยฃ0.755.17%
2012ยฃ0.72-49.61%
2011ยฃ1.42-6.27%
2010ยฃ1.5236.82%
2009ยฃ1.11-28.28%
2008ยฃ1.5524.96%
2007ยฃ1.249.24%
2006ยฃ1.133.21%
2005ยฃ1.10-6.29%
2004ยฃ1.1718.8%
2003ยฃ0.9930.39%
2002ยฃ0.7652.45%
2001ยฃ0.501.77%
2000ยฃ0.49

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ6.60 1,456.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ5.30 1,150.71%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
ยฃ0.99 133.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ10.94 2,479.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ1.93 356.04%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
ยฃ2.69 533.79%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
ยฃ2.94 592.40%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
-ยฃ3.03-814.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
ยฃ0.57 34.09%๐Ÿ‡ฎ๐Ÿ‡ณ India